Cytokine Storm Signature in Patients with Moderate and Severe COVID-19.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Aug 2022
Historique:
received: 29 06 2022
revised: 03 08 2022
accepted: 04 08 2022
entrez: 26 8 2022
pubmed: 27 8 2022
medline: 30 8 2022
Statut: epublish

Résumé

Hypercytokinemia, found in SARS-CoV-2 infection, contributes to multiple organ dysfunctions with acute respiratory distress syndrome, shock etc. The aim of this study was to describe cytokine storm signatures in patients with acute COVID-19 and to investigate their influence on severity of the infection. Plasma levels of 47 cytokines were investigated in 73 patients with moderate and severe COVID-19 (41 and 32, respectively) and 11 healthy donors (HD). The most elevated levels comparing patients and the HD were observed for seven pro-inflammatory cytokines (IL-6, IL-8, IL-15, IL-18, IL-27, IFNγ, TNFα), three chemokines (GROα, IP-10, MIG), two anti-inflammatory cytokines (IL-1RA, IL-10), and two growth factors (G-CSF, M-CSF). The patients with severe disease had significantly higher levels of FGF-2/FGF-basic, IL-1β, and IL-7 compared to the HD. The two groups of patients differed from each other only based on the levels of EGF, eotaxin, and IL-12 p40. Pneumonia lung injury, characterized by computer tomography, positively correlated with levels of EGF, IP-10, MCP-3 levels and negatively with IL-12 p40. Pro-inflammatory factors including IL-6, TNFα, and IP-10 negatively correlated with the frequency of the circulating T-helper17-like cells (Th17-like) and follicular Th cells that are crucial to develop SARS-CoV-2-specific plasma cells and memory B cells. Obtained data on the cytokine levels illustrate their influence on progression and severity of COVID-19.

Identifiants

pubmed: 36012146
pii: ijms23168879
doi: 10.3390/ijms23168879
pmc: PMC9408700
pii:
doi:

Substances chimiques

Chemokine CXCL10 0
Cytokines 0
Interleukin-6 0
Tumor Necrosis Factor-alpha 0
Interleukin-12 187348-17-0
Epidermal Growth Factor 62229-50-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2022-301

Références

Front Genet. 2021 Jun 07;12:680646
pubmed: 34163532
Sci Rep. 2016 May 05;6:25359
pubmed: 27146253
Clin Immunol. 2021 Feb;223:108652
pubmed: 33333256
J Med Virol. 2006 Apr;78(4):417-24
pubmed: 16482545
Viruses. 2022 May 18;14(5):
pubmed: 35632823
Nat Med. 2020 Oct;26(10):1623-1635
pubmed: 32807934
Front Immunol. 2020 Nov 26;11:596553
pubmed: 33324414
Sci Immunol. 2020 Jul 15;5(49):
pubmed: 32669287
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
J Allergy Clin Immunol. 2020 Jul;146(1):89-100
pubmed: 32407836
Cell Death Dis. 2020 Nov 6;11(11):957
pubmed: 33159040
Nat Med. 2020 Sep;26(9):1428-1434
pubmed: 32661393
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Am J Respir Crit Care Med. 2005 Apr 15;171(8):850-7
pubmed: 15657466
Immunity. 2011 Jan 28;34(1):108-21
pubmed: 21215658
Front Immunol. 2021 May 14;12:664209
pubmed: 34054832
Clin Chim Acta. 2020 Sep;508:122-129
pubmed: 32417210
Trends Immunol. 2007 Jan;28(1):33-8
pubmed: 17126601
Sci Rep. 2016 Feb 10;6:20686
pubmed: 26861911
Sci Rep. 2016 May 27;6:26494
pubmed: 27231124
Front Immunol. 2021 May 17;12:659419
pubmed: 34079547
Front Cardiovasc Med. 2021 Dec 17;8:785738
pubmed: 34977191
Cytometry A. 2013 Jun;83(6):530-2
pubmed: 23504907
Sci Transl Med. 2013 Mar 13;5(176):176ra32
pubmed: 23486778
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
Cytokine. 2018 Apr;104:8-13
pubmed: 29414327
Nat Commun. 2020 Jul 6;11(1):3434
pubmed: 32632085
Sci Immunol. 2020 Sep 17;5(51):
pubmed: 32943497
Oncoimmunology. 2020 Aug 25;9(1):1807836
pubmed: 32939324
Pathogens. 2021 Oct 30;10(11):
pubmed: 34832564
Viruses. 2021 Apr 27;13(5):
pubmed: 33925492
J Leukoc Biol. 2021 Jan;109(1):55-66
pubmed: 32930456
Sci Immunol. 2021 Feb 23;6(56):
pubmed: 33622974
JCI Insight. 2020 May 21;5(10):
pubmed: 32324595
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415897
JCI Insight. 2021 Jan 11;6(1):
pubmed: 33232303
Vaccines (Basel). 2021 Mar 03;9(3):
pubmed: 33802310
Cytokine. 2012 Sep;59(3):467-78
pubmed: 22704694
Science. 2020 Sep 4;369(6508):
pubmed: 32669297
BMC Infect Dis. 2021 Aug 3;21(1):738
pubmed: 34344353
Mol Med. 2020 Oct 29;26(1):97
pubmed: 33121429
Front Immunol. 2021 Jun 28;12:680188
pubmed: 34262564
World Allergy Organ J. 2021 Mar;14(3):100521
pubmed: 33589865
Nat Med. 2020 Jul;26(7):1070-1076
pubmed: 32514174
Scand J Immunol. 2021 Mar;93(3):e12989
pubmed: 33113222
J Allergy Clin Immunol. 2021 Jul;148(1):40-52
pubmed: 33485651
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Rev Immunol. 2012 Feb 17;12(3):191-200
pubmed: 22343568
Front Immunol. 2021 Dec 06;12:763292
pubmed: 34938289
Am J Kidney Dis. 2022 Feb;79(2):257-267.e1
pubmed: 34710516
Eur J Immunol. 2019 Oct;49(10):1457-1973
pubmed: 31633216
Cell. 2020 Sep 17;182(6):1401-1418.e18
pubmed: 32810439
Biomed Pharmacother. 2022 Jan;145:112419
pubmed: 34781146
Immunity. 2019 May 21;50(5):1132-1148
pubmed: 31117010
Cytokine Growth Factor Rev. 2021 Apr;58:82-91
pubmed: 33573850
Immunity. 2020 Oct 13;53(4):864-877.e5
pubmed: 32791036
Cell. 2022 Mar 3;185(5):916-938.e58
pubmed: 35216673
J Pers Med. 2021 Mar 12;11(3):
pubmed: 33809027
Open Forum Infect Dis. 2020 Nov 26;8(2):ofaa574
pubmed: 33553467
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Pathogens. 2022 Feb 01;11(2):
pubmed: 35215138
Eur J Clin Invest. 2021 Jan;51(1):e13429
pubmed: 33058143
Cytokine Growth Factor Rev. 2020 Aug;54:62-75
pubmed: 32513566
J Infect Dis. 2020 Aug 4;222(5):746-754
pubmed: 32563194
Semin Immunol. 2021 Jun;55:101545
pubmed: 34865933
Viruses. 2021 Sep 30;13(10):
pubmed: 34696395
Virol J. 2021 Jun 4;18(1):117
pubmed: 34088317
J Heart Lung Transplant. 2017 Mar;36(3):305-314
pubmed: 27793518

Auteurs

Olga Kalinina (O)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Alexey Golovkin (A)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Ekaterina Zaikova (E)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Arthur Aquino (A)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Vadim Bezrukikh (V)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Olesya Melnik (O)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Elena Vasilieva (E)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Tatiana Karonova (T)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Igor Kudryavtsev (I)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Institute of Experimental Medicine, 197376 St. Petersburg, Russia.

Evgeny Shlyakhto (E)

Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH